Life insurance: Genomic stratification and risk classification

European Journal of Human Genetics

Volumn 22, Issue 5, 2014, Pages 575-579

  Joly, Yann ^a   Burton, Hilary ^b   Knoppers, Bartha Maria ^a   Feze, Ida Ngueng ^a   Dent, Tom ^b   Pashayan, Nora ^c   Chowdhury, Susmita ^b   Foulkes, William ^a   Hall, Alison ^b   Hamet, Pavel ^d   Kirwan, Nick ^e   Macdonald, Angus ^f   Simard, Jacques ^g   Van Hoyweghen, Ine ^h  

^a MCGILL UNIVERSITY   (Canada)

^b PHG FOUNDATION   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Association of British Insurers   (United Kingdom)

^f HERIOT WATT UNIVERSITY   (United Kingdom)

^g UNIVERSITÉ LAVAL   (Canada)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CANCER RESEARCH; GENETIC RISK; GENOMICS; HUMAN; INSURANCE; LEGAL ASPECT; MEDICAL INFORMATION; MEDICAL SOCIETY; PREDICTIVE VALUE; PRIORITY JOURNAL; RESEARCH ETHICS; RISK ASSESSMENT; SOCIAL ASPECT; SYMPOSIUM; ETHICS; GENETIC ASSOCIATION; GENETIC SCREENING; LEGISLATION AND JURISPRUDENCE;

CANADA; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; INSURANCE, LIFE; RISK ASSESSMENT;

EID: 84898824655     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.228     Document Type: Article

References (41)

1. Knoppers BM, Godard B, Joly Y: Life insurance and genetics: a comparative international overview. In: Rothstein MA (ed.) Genetics and Life Insurance: Medical Underwriting and Social Policy. Cambridge, MA, USA: MIT Press, 2004; pp 173-194.
2. Lemmens T, Joly Y, Knoppers BM: Genetic and life insurance: a comparative analysis. GenEdit 2004; 2: 1-15.
3. Zurich Insurance Co. v. Ontario (Human Rights Commission): [1992] 2 S.C.R. 321.
4. Rothstein MA, Anderlik MR: What is genetic discrimination, and when and how can it be prevented? Genet Med 2001; 3: 354-358.
5. Rothstein MA, Joly Y: Genetic information and insurance underwriting: contemporary issues and approaches in the global economy insurance. In: Atkinson P, Glasner P, Lock M (eds) Handbook of Genetics and Society: Mapping the New Genomic Era. London, UK and New York, NY, USA: Routledge, 2009.
6. Prince A: Regulation of Genetic Information in Life, Long Term Care, and Disability Insurances: 50 States SurveyAvailable at: https://www. disabilityrightslegalcenter.org/about/documents/GeneticsStateSurveyFinal.pdf: Cancer Legal Resource Center, 2012 (Last accessed 11 March 2013).
7. Otlowski M, Taylor S, Bombard Y: Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet 2012; 13: 1-6, 22.
8. Knoppers BM, Joly Y: Physicians, genetics and life insurance. Canad Med Assoc J 2004; 170: 1421-1423.
9. O'Neil M: Genetic information, life insurance and social justice. Monist 2006; 89: 567-592.
10. Council of Europe. Consultation document on predictivity, genetic testing and insurance. In: (CDBI) SCoB (ed.): DH-BIO/INF (2012)1, 2012.
11. Joly Y, Ngueng Feze I, Simard J: Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med 2013; 11: 25.
12. Armstrong K, Weber B, FitzGerald G et al: Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Am J Med Genet 2003; 120A: 359-364.
13. Godard B, Pratte A, Dumont M, Simard-Lebrun A, Simard J: Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling. Genet Test 2007; 11: 45-54.
14. Kirkland SA, Raina PS, Wolfson C et al: Exploring the acceptability and feasibility of conducting a large longitudinal population-based study in Canada. Canad J Aging 2009; 28: 231-242.
15. Becker F, Van El CG, Ibarreta D et al: Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Eur J Hum Genet 2001; 19: S6-S44.
16. Pashayan N, Pharoah P: Translating genomics into improved population screening: hype or hope? Hum Genet 2011; 130: 19-21.
17. Freedman AN, Seminara D, Gail MH et al: Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005; 97: 715-723.
18. Burton H: Genetics and Mainstream Medicine: Service Development and Integration. Cambridge, UK: PHG Foundation, 2011.
19. Pashayan N, Duffy S, Chowdhury S et al: Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 2011; 104: 1656-1663.
20. Macdonald AS, Yu F: The impact of genetic information on the insurance industry: conclusion from the 'bottom-up' modeling programme. ASTIN Bull 2011; 41: 343-376.
21. Zimmern RL, Khoury MJ: The impact of genomics on public health practice: the case for change. Public Health Genom 2012; 15: 118-124.
22. Speicher MR, Geigl JB, Tomlinson IP: FRCPath: effect of genome-wide association studies, direct-to-consumer genetic testing, and high-speed sequencing technologies on predictive genetic counselling for cancer risk. Lancet Oncol 2010; 11: 890-898.
23. llumina: Applications/SNP Genotyping and CNV Analysis-Whole-Genome Genotyping and Copy Number Variation AnalysisAvailable at: www.illumina.com/ applications/details/sequencing/dnasequencing.ilmn (Last accessed 11 March 2013).
24. Gene By Gene: DNA DTC-Next-Generation SequencingAvailable at: http://www. dnadtc.com/(Last accessed 11 March 2013).
25. Drmanac R: The advent of personal genome sequencing. Genet Med 2011; 13: 188-190.
26. Biesecker LG, Burke W, Kohane I, Plon SE, Zimmern R: Next-generation sequencing in the clinic: are we ready? Nat Rev Genet 2012; 13: 818-824.
27. Dressler LG: Disclosure of research results from cancer genomic studies: state of the science. Clin Cancer Res 2009; 4270-4276.
28. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007; 9: 665-674.
29. Wolf SM, Crock BN, Van Ness B et al: Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012; 14: 361-384.
30. Government of Canada: Public Opinion Research Into Genetic Privacy Issues. Ottawa, Canada: Pollara Research and Earnscliffe Research and Communications, 2003.
31. Keogh LA, van Vliet CM, Studdert DM et al: Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? Med J Aust 2009; 191: 255-258.
32. Nakayama M, Osaki S, Shimokawa H: Validation of mortality risk stratification models for cardiovascular disease. Am J cardiol 2011; 108: 391-396.
33. Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ: Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796-2803.
34. Macdonald A, McIvor K: Application of a polygenic model of breast and ovarian cancer to critical illness insurance. Ann Actuarl Sci 2006; 1: 319-343.
35. American Academy of Actuaries. Risk classification in voluntary life insurance. Issue Brief 1997; SPRING 1997: 1-4.
36. Holland S, Heidenreich W, Itskovich I: Stratifying long-term care risk by cardiovascular risk factor-an analysis of claims experience with atrial fibrillation. J Insur Med 2006; 38: 253-258.
37. Macdonald AS: Genetic Factors in Life Insurance: Actuarial Basis: Encyclopedia of Life Science (ELS). Chichester, UK: Wiley, 2009.
38. Phoenix Strategic Perspectives Inc.: Survey of Canadians on Privacy-Related Issues. Ottawa, Canada: Office of the Privacy Commissioner of Canada, 2013.
39. Van Hoyweghen I: Taming the wild life of genes by law? Genes reconfiguring solidarity in private insurance. N Genet Soc 2010; 29: 431-455.
40. Geelen E, Horstman K, Marcelis CL, Doevendans PA, Van Hoyweghen I: Unravelling fears of genetic discrimination: an exploratory study of Ducth HCM families in an era of genetic non-discrimination acts. Eur J Hum Genet 2012; 20: 1018-1023.
41. Van Hoyweghen I, Rebert L: Your genes in insurance: from genetic discrimination to genomics solidarity. Person Med 2012; 9: 871-877.